Literature DB >> 33813847

Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension.

Leah B Rethy1, Matthew J Feinstein2, Chad J Achenbach3, Raymond R Townsend4, Adam P Bress5, Sanjiv J Shah2, Jordana B Cohen4,6,7.   

Abstract

[Figure: see text].

Entities:  

Keywords:  antihypertensive agents; cardiovascular diseases; epidemiology; heart failure; human immunodeficiency virus; kidney diseases

Mesh：

Substances：

Year:  2021        PMID： 33813847      PMCID： PMC8119362          DOI： 10.1161/HYPERTENSIONAHA.120.16263

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


  38 in total

Review 1.  Cardiovascular protection using beta-blockers: a critical review of the evidence.

Authors:  Sripal Bangalore; Franz H Messerli; John B Kostis; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

2.  Sensitivity Analysis in Observational Research: Introducing the E-Value.

Authors:  Tyler J VanderWeele; Peng Ding
Journal:  Ann Intern Med       Date:  2017-07-11       Impact factor: 25.391

Review 3.  Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

Authors:  Matthew J Feinstein; Priscilla Y Hsue; Laura A Benjamin; Gerald S Bloomfield; Judith S Currier; Matthew S Freiberg; Steven K Grinspoon; Jules Levin; Chris T Longenecker; Wendy S Post
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

4.  Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials.

Authors:  Costas Thomopoulos; George Bazoukis; Costas Tsioufis; Giuseppe Mancia
Journal:  J Hypertens       Date:  2020-09       Impact factor: 4.844

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 6.  Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.

Authors:  Yousef Shahin; Junaid Alam Khan; Nehemiah Samuel; Ian Chetter
Journal:  Atherosclerosis       Date:  2011-02-26       Impact factor: 5.162

Review 7.  Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.

Authors:  William M Schultz; Heval M Kelli; John C Lisko; Tina Varghese; Jia Shen; Pratik Sandesara; Arshed A Quyyumi; Herman A Taylor; Martha Gulati; John G Harold; Jennifer H Mieres; Keith C Ferdinand; George A Mensah; Laurence S Sperling
Journal:  Circulation       Date:  2018-05-15       Impact factor: 29.690

8.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study.

Authors:  Jordana B Cohen; Debbie L Cohen; Daniel S Herman; John T Leppert; James Brian Byrd; Vivek Bhalla
Journal:  Ann Intern Med       Date:  2020-12-29       Impact factor: 25.391

10.  Coronary Microvascular Dysfunction in HIV: A Review.

Authors:  Leah Rethy; Matthew J Feinstein; Arjun Sinha; Chad Achenbach; Sanjiv J Shah
Journal:  J Am Heart Assoc       Date:  2019-12-19       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.